Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxygen Enhanced MRI Measurement in Head and Neck Cancer: Validation and Efficacy of Response.

NCT03646747 is registered in ClinicalTrials.gov with Sally Falk as lead sponsor.

NCT NCT03646747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03646747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxygen Enhanced MRI Measurement in Head and Neck Cancer: Validation and Efficacy of Response.
Lead sponsor
Sally Falk
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2018
Completion date
December 31, 2021
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer